Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Bradykinin Receptor
    (4)
  • CDK
    (3)
  • Endothelin Receptor
    (2)
  • PD-1/PD-L1
    (2)
  • PROTACs
    (2)
  • Apoptosis
    (1)
  • Autophagy
    (1)
  • Cytochromes P450
    (1)
  • EGFR
    (1)
  • Others
    (23)
TargetMol | Tags By ResearchField
  • Metabolism
    (2)
  • Cancer
    (1)
  • Immune System
    (1)
  • Infection
    (1)
  • Inflammation
    (1)
Filter
Search Result
Results for "

rb 2

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    22
    TargetMol | All_Pathways
  • Peptide Products
    4
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    3
    TargetMol | Inhibitory_Antibodies
  • Dye Reagents
    7
    TargetMol | All_Dye_Reagents
  • PROTAC Products
    3
    TargetMol | PROTAC
  • Natural Products
    4
    TargetMol | Natural_Products
  • Recombinant Protein
    66
    TargetMol | Recombinant_Protein
  • Antibody Products
    59
    TargetMol | Antibody_Products
  • Reference Standards
    2
    TargetMol | Standard_Products
  • 13
    TargetMol | All_Pathways
Ginsenoside Rb2
Ginsenoside C
T391911021-13-9
Ginsenoside Rb2 (Ginsenoside C) found in species of Panax, upregulating GPR120 gene expression.
  • $31
In Stock
Size
QTY
TargetMol | Citations Cited
Ginsenoside Rb2 (Standard)
TMSM-268911021-13-9
Ginsenoside Rb2 (Standard) is a reference standard for research and analysis in studies involving Ginsenoside Rb2. Ginsenoside Rb2 (Ginsenoside C) found in species of Panax, upregulating GPR120 gene expression.
  • $495
7-10 days
Size
QTY
Schisandrol B
Wuweizi alcohol-B, TJN-101, Schizandrol B, Gomisin A, Gamma-Schisandrin, Besigomsin
T6S191758546-54-6
1. Schisandrol B (Besigomsin) may exert neuroprotective effects by attenuating the microglia-mediated neuroinflammatory response via inhibiting the TLR4-mediated NF-κB and MAPKs signaling pathways. 2. Schisandrol B has anti-inflammatory property, potentially result from the inhibition of COX-2, iNOS, IL-6, TNF-α and NO through the down-regulation of RIP2 and NF-κB activation. 3. Schisandrol B induces marked protective effects against hepatic and renal injury induced by CCl(4) exposure through differential regulation of the MAPK signal transduction pathway. 4. Schisandrol B significantly inhibits cell proliferation in a dose-dependent manner, due to cell cycle arrest in the G1 phase with the downregulation of cyclin D1 expression and Retinoblastoma (RB) phosphorylation.
  • $65
In Stock
Size
QTY
Schisandrol B (Standard)
TMSM-289158546-54-6
Schisandrol B (Standard) is a reference standard for research and analysis in studies involving Schisandrol B. 1. Schisandrol B (Besigomsin) may exert neuroprotective effects by attenuating the microglia-mediated neuroinflammatory response via inhibiting the TLR4-mediated NF-κB and MAPKs signaling pathways. 2. Schisandrol B has anti-inflammatory property, potentially result from the inhibition of COX-2, iNOS, IL-6, TNF-α and NO through the down-regulation of RIP2 and NF-κB activation. 3. Schisandrol B induces marked protective effects against hepatic and renal injury induced by CCl(4) exposure through differential regulation of the MAPK signal transduction pathway. 4. Schisandrol B significantly inhibits cell proliferation in a dose-dependent manner, due to cell cycle arrest in the G1 phase with the downregulation of cyclin D1 expression and Retinoblastoma (RB) phosphorylation.
  • $939
7-10 days
Size
QTY